Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2500 participants.

Also called NCT02053038

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 2,500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02053038
Other papers using this trial's data
  • Coronary Revascularization Guided With Fractional Flow Reserve or Instantaneous Wave-Free Ratio: A 5-Year Follow-Up of the DEFINE FLAIR Randomized Clinical Trial JAMA cardiology, 2025-01-01 DOI, PubMed 39412778, PMC11581635 PubMed links an erratum for this paper. Erratum: PMID 39774481 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Belgium, Egypt, Finland, Germany, Italy, Japan, Latvia, Netherlands, Portugal, Saudi Arabia, South Africa, South Korea, Spain, Türkiye, United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02053038. Randomized; double masking; primary purpose diagnostic. Start 2014-01 (actual); primary completion 2021-01-19 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
Acronym
DEFINE-FLAIR
Intervention (Device)
iFR
Intervention (Device)
FFR
Lead sponsor
Imperial College London (class: other)

Record details

Record id
cardio:ct-nct02053038
Content hash
f939c4ad5bf03b3b4c7be75184c856bbdca1470196eb8f79ae1cd13b33281cc5